Canada’s psilocybin landscape is shifting fast in 2026 — from new clinical research partnerships to evolving policy signals. Here’s what the latest developments actually mean for people who use, buy, or microdose magic mushrooms in Canada.
Tag Archives: psilocybin clinical trials
A $2-million investment in psychedelic medicine at St. Joseph’s Healthcare Hamilton is accelerating psilocybin research in Canada. We break down what this means for therapeutic access, product quality, and the future of the magic mushroom community.